Acrannolife Genomics is revolutionizing healthcare with Trunome®, a US-patented platform that redefines organ transplant care. Using cfDNA markers, Trunome® offers early and precise detection of organ rejection and infection, enabling timely interventions that enhance patient outcomes. With over 98% accuracy, Trunome® has become the trusted choice for leading transplant specialists, delivering unmatched results across heart, liver, kidney, lung, and pancreas transplants. Acrannolife Genomics is committed to making this advanced technology accessible and affordable, setting new standards in patient care. Acrannolife Genomics is on a mission to impact over a billion lives positively.
Driven by an unstoppable passion for improving people’s health, ALS provides affordable solutions that alleviates the donor organ shortage. At ALS, we maximize the full potential of each organ and ensure that every organ is an opportunity for another patient to live. With ALS expect more.
Aferetica is an innovative SME, founded by managers with thirty years’ experience in blood purification who wanted to leverage their competence in purification therapies and the know-how in biomedical technologies in order to apply aphaeresis techniques in new fields, such as ex-situ organ management for transplantation.
Aferetica’s mission is to drive and incentive the creation of a network, which must be able to create, validate and use aphaeresis therapies in clinical practice, initiating their use in new clinical areas.
Aferetica wants to meet current transplantation needs, transforming organ preservation in organ recovering and regeneration, through the combination of both aphaeresis and perfusion techniques.
This mission leads to the design and the development of integrated systems for:
- Organ Transportation: PerTravel (kidney, liver, heart, pancreas)
- Organ ex-situ treatment:
- PerLife: kidney and liver versatile (4-37 °C) ex-situ perfusion
- PerLungs: ex-situ lungs treatment
- Ex-situ organ purification: PerSorb
At Astellas, we are relentless in our pursuit of scientific progress and in identifying unmet medical needs by monitoring the changes in healthcare from multiple perspectives. We are committed to the realization of greater VALUE by patients and healthcare systems around the world. We achieve this by leveraging our strengths to create innovative new drugs and to find solutions that drive patient access to healthcare and better outcomes.
Başkent University is a private university in Ankara, Turkey. The university was founded on 13 January 1994 by Professor Dr. Mehmet Haberal. The university center is located in Ankara and also has medical and research centers and dialysis centers all around Turkey.
Benta Pharma Industries – BPI is a leader in the pharmaceutical industry committed to manufacturing high quality pharmaceutical products as well as medical devices, thus improving human health and well-being.
Our purpose is grounded in our commitment to manufacture the finest quality pharmaceutical products and medical devices to ensure that you get the best possible healthcare. Over the years, we have become leaders in the industry.
BPI has become a front runner in the manufacturing of enhanced formulations for the treatment of a variety of diseases ranging from cardiovascular to diseases of the central nervous system, diabetes, dermatology, urology, transplant, anesthesia, and many more… In addition to that, BPI also produces oncology, biotech, and sterile products.
Founded in 1978, Biogen is a leading biotechnology company pioneering innovative science to deliver new medicines to transform patients’ lives and to create value for shareholders and our communities. We apply deep understanding of human biology and leverage different modalities to advance first-in-class treatments or therapies that deliver superior outcomes.
For over a decade, Bridge to Life has been the trusted, go-to brand in the organ transplant community and recognized global leader in organ preservation and perfusion solutions. In addition to its commercialized solutions business, Bridge to Life has a machine perfusion product for livers in development for the US and commercialized in the EU.
We are committed to improving transplant patient outcomes by providing innovative and intelligent solutions throughout the entire patient journey. With over 20 years of leadership in 4 areas of transplant innovation, our understanding of transplant patients and care teams allows us to develop solutions to support the entire transplant journey.
Doğsan, the first suture manufacturer of Turkey, Middle East and Balkan states, has been founded in 1970 and have a long history in suture manufacturing.
Dr. Franz Koehler Chemie GmbH is a family-owned and managed pharmaceutical company with long history and experience. We are specialized in organ preservation solutions, intensive care medicine, antidotes and contrast agents. With our highly specialized portfolio of niche products in the field of organ-protecting solutions, we have gained market leadership through our profound long-term know-how and tremendous responsibility.
Donation & Transplantation Institute (DTI Foundation) is a non-profit organization committed to improve society’s quality of life through donation and transplantation of organs, tissues and cells.
We are committed to improving organ donation and transplantation systems. We provide training and consulting services to healthcare professionals and institutions, aiming to enhance organ donation rates, transplantation processes, and ultimately save more lives.
Specialist for over 40 years in the design and manufacturing of packaging.
Range Vitalpack EVO.
Packaging for transporting organs.
ESOT is committed to achieving excellence in organ transplantation and is focused on improving patient outcomes in transplantation. It is a highly influential international organisation that hosts a biennial congress, bringing together approximately 3,500 experts to explore and discuss the latest scientific research. ESOT collaborates with leading transplantation experts and has a remarkable track record of supporting research, education, and influencing European policy changes.
From pre-transplant protocols and screening to post-transplant diagnostics and rejection monitoring, the journey is perpetual. Enhancing patient outcomes necessitates the utilization of cutting-edge technology throughout every step of the patient’s path. This is where Eurofins Transplant excels. Eurofins Transplant revolutionizes transplant testing, offering breakthrough solutions that empower both patients and providers alike. Comprising five key divisions within Eurofins: CellTX, Donor & Product Testing, Ascend Clinical, Viracor, and Transplant Genomics, these organizations collectively influence every critical stage in the transplant journey.
The subsequent company overviews will elucidate how each individual organization contributes to this pioneering field.
GEISTER MEDIZINTECHNIK GMBH is a manufacturer and system supplier of surgical instruments for conventional and minimally invasive surgery with a focus on cardiac, thoracic, vascular and neurosurgery as well as joint surgery.
Glycosorb® ABO. The specific treatment method available for ABO-incompatible transplantation and transfusion. Glycosorb® ABO bio-specifically binds the anti-A/B IgG and IgM antibodies, thus facilitating blood group-incompatible transplantation and transfusion. This groundbreaking medical device has garnered global recognition, with over 7,000 blood group-incompatible transplants performed worldwide since its inception in 2001.
Hamad Medical Corporation (HMC) is the main provider of secondary and tertiary healthcare in Qatar and one of the leading hospital providers in the Middle East. HMC manages 12 specialist and community hospitals as well as the Qatar Organ Donation Center-(Hiba) and Qatar Center for Organ Transplantation.
HAYAT: A National Initiative for Life
"HAYAT," the Arabic word for "LIFE," is a pivotal initiative led by the UAE Ministry of Health aims to promote organ and tissue donation, save lives, and improve patient outcomes. It aligns with international standards, raises awareness, and facilitates transparent donation processes. HAYAT supports the UAE's goal of becoming a regional hub for organ transplantation, enhancing healthcare capacity building capabilities and fostering a culture of donation.
The initiative is instrumental in establishing the UAE as an academic leader in the field, driving innovation and knowledge-sharing through the development of specialized programs, workshops, congresses, and courses. These educational and capacity-building efforts position the UAE at the forefront of organ donation and transplantation, locally, regionally and internationally.
In 1968 and 1998, Georges Gaston Lopez, received a kidney and liver transplant. Later, his son, Georges Antoine Lopez, founded Institut Georges Lopez (known as IGL), a company entirely devoted to donor organ preservation.
It is because we understand what it feels like to be waiting for an organ, that we are committed to constantly provide safe and innovative products, in order to ensures transplantation success and improves patient’s quality of life.
From our award-winning international iTransplant® Platform facilitating critical organ donation activity and providing transplant programs next-generation solutions, to our iReferral® interfaces automating the key donor referral process, and our iTx App enabling speed across the donation-transplant ecosystem, InVita is proud to enable the work of donation and transplantation heroes.
Indian Society of Organ Transplantation (ISOT) has been honored with the 2024 Best Supportive Societies Award by National Organ & Tissue Transplant Organisation, Ministry of Health & Family Welfare, Government of India for the exceptional contribution to organ donation and transplantation. Join us at ISOT 2024 in Ahmedabad from 17-20 October 2024
JamHUB Solutions, a Portuguese innovation leader, specializes in technology-driven problem-solving. JamHUB provides end-to-end applications, leveraging cutting-edge technologies like AI. Our flagship product, TransplantHUB, delivers an integrated system for managing organ donation and transplant ecosystems, ensuring a seamless, efficient process and enabling medical teams to focus on patient journey management.
www.jamhubsolutions.com www.transplanthub.com
Natera provides advanced DNA technology that enables transplant providers to deliver quality, personalized care. As a diagnostics company with proprietary bioinformatics and molecular technology, we’ve performed more than 10 million cfDNA tests and are dedicated to improving kidney, heart and lung care for good. Learn more at natera.com/organ-health.
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. Neovii was founded in 2013 by the acquisition of Fresenius Biotech inheriting more than three decades of experience in speciality pharmaceuticals and has a presence in nearly 40 countries worldwide. Neovii’s global headquarters are located in Rapperswil, Switzerland, with its biologics manufacturing site and German operations located in Gräfelfing, Germany.
Omixon is a global transplantation diagnostic company with a mission to provide histocompatibility laboratories with innovative technologies to improve transplant outcomes. Omixon is headquartered in Budapest, Hungary, with operations in the United States, Brazil and the Netherlands serving more than 100 laboratories worldwide.
Building on multidisciplinary competences in bioinformatics, software engineering, molecular biology and regulatory science, Omixon transforms molecular biology innovations into state-of-the-art products in transplant diagnostics.
Omixon was the first to successfully introduce a Next-Generation sequencing (NGS) based HLA genotyping kit and software in 2014 by bringing Holotype HLA assay and HLA Twin software to market. HLA Twin is a leading software for high-resolution HLA genotyping and is used in more than 100 laboratories worldwide.
Omixon was the first to release a high resolution HLA genotyping product NanoTYPE HLA with less than 5 hours turnaround time on the Oxford Nanopore sequencing platform complemented by NanoTYPER analysis software.
Omixon is the first to bring to market a donor-derived cell-free DNA kit HoloGRAFT for laboratories with donor-informative genetic markers with primer and probe sequences that are absent in the patient genotype by design.
From the success of LifePort Kidney Transporter, Organ Recovery Systems introduces the next generation of preservation with the upcoming launch of the LifePort Liver Transporter. In addition to providing innovative products, ORS delivers support via the LifePort mobile app, 24/7 Perfusion Helpline, Instructor-Led Training, and online Client Community.
OrganOx is changing paradigms in transplant through the use of normothermic machine perfusion technology designed to preserve and aid the identification of viable donor organs without compromising outcomes. In a European randomized clinical trial, preservation of livers with the Organonx metra® device resulted in 50% fewer discarded organs compared to static cold storage and 20% more transplanted livers.
QIAGEN is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. Our mission is to make improvements in life possible by enabling our customers to achieve outstanding success and breakthroughs in life sciences research, applied testing, pharma and molecular diagnostics.
The QUOD biobank facilitates research into organ donation and transplantation by providing matched samples and clinical data from appropriately consented/authorised organ donors. QUOD collects blood, urine and tissue samples including kidney, liver, ureter, spleen and heart. We encourage researchers worldwide to apply to access our unique bioresource.
S.A.L.F. S.p.A Laboratorio Farmaceutico was founded on August 25, 1921. S.A.L.F stands for ‘Anonymous Pharmacological Laboratory Company’ and it was originally a private enterprise that was among the first companies to study the curative properties of the aqueous solutions and to develop a whole wide range of injectables for hospital use. The manufacturing site, which used to be located in the center of Bergamo, at the end of 1960’s moved to Cenate Sotto and decided to focus its production on the injectable, irrigation and dialysis solutions. Today the production plant covers 14000 square meters of production departments, labs, warehouses, and offices.
Over 100 Years of Excellence...and Our Journey Continues!
The world’s finest surgical instruments have been designed and manufactured by the Scanlan Family since 1921.
You deserve the best. Experience the Scanlan difference at Exhibit #9.
AST is committed to nurturing the growth of transplantation across Asia by sharing scientific knowledge, enhancing clinical practices, and providing ongoing education, all with a strong emphasis on ethical practices.
The mission of The Transplantation Society is to provide global leadership in the practice of human transplantation. The responsibility of The Transplantation Society is to establish guidelines of clinical practice, advance programs of education, and to promote ethical standards for clinical care and scientific investigation.
The International Society of Nephrology (ISN) is a global professional association dedicated to advancing kidney health worldwide since 1960 through education, grants, research, and advocacy.
The ISN, through its members and in collaboration with national and regional societies, engages 30,000 health professionals from across the globe to reduce the burden of kidney diseases and provide optimal health care for patients.
Mallinckrodt is a global business consisting of multiple wholly owned subsidiaries that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Therakos is a specialty brand of Mallinckrodt that focuses on the delivery of ECP Immunomodulation.
To learn more about Therakos ECP Immunomodulation visit www.therakos.eu.
As part of Thermo Fisher Scientific, we offer products and services to advance the science of transplant diagnostics. Our solutions help transplant labs and clinical teams provide personalized care across the patient experience.
Dr. Paul Terasaki founded One Lambda™ in 1984 to develop tests to improve how laboratories match and monitor transplant recipients and donors. Since then, our HLA typing and antibody detection assays have been trusted by transplant laboratories worldwide. Clinicians also rely on data from our patient monitoring tests to make important decisions about post-transplant therapies.
Transplantation is life-changing for recipients, and clinical diagnostics play a vital role in supporting all phases of treatment. Through our commitment to scientific innovation, product quality, patient advocacy, and excellent customer service, we are helping the transplant community raise the standard of care and improve patient and family outcomes.
Starting on May 20, 1933 with five planes and fewer than 30 employees, our journey continues today as the airline flying to the most countries in the world – celebrating our 90th year.
Our growing passion over the years has earned us the title of the airline that flies to most countries in the world. Today we conduct flights to 120 countries from our new home, Istanbul Airport, with a young fleet of 462 aircraft. We proudly carry the Turkish flag across the globe, opening doors to the wider world for our passengers.
Being aware of the high social responsibility of working as a NGO in the field of organ transplantation and operating in cooperation with all constituting actors, our mission is to contribute to the improvement of transplant services at the highest level both nationwide and worldwide.
Seed of life & Fruit of sharing VITALLINK
The WTGF organises international sporting events and works to raise awareness about organ donation. Through initiatives like the World Transplant Games, research, conferences, wellness programs, we aim to emphasize the importance of physical activity and a healthy lifestyle for the long-term well-being of transplant recipients.